BlackRock Investment Management’s Minerva Neurosciences NERV Stock Holding History

BlackRock Investment Management’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$878K	Sell	9,338 -122	-1%	-$12.5K	﹤0.01%	2767
2016 Q3	$1.07M	Buy	9,460 +1,747	+23%	+$170K	﹤0.01%	2624
2016 Q2	$630K	Buy	7,713 +7,421	+2,541%	+$472K	﹤0.01%	2928
2016 Q1	$14K	Hold	292	–	–	﹤0.01%	3488
2015 Q4	$14K	Buy	292 +21	+8%	+$877	﹤0.01%	3556
2015 Q3	$11K	Hold	271	–	–	﹤0.01%	3649
2015 Q2	$13K	Buy	271 +148	+120%	+$6.32K	﹤0.01%	3613
2015 Q1	$5K	Buy	123 +20	+19%	+$828	﹤0.01%	3858
2014 Q4	$5K	Hold	103	–	–	﹤0.01%	3914
2014 Q3	$5K	Buy	+103	New	+$5.48K	﹤0.01%	3892

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Investment Management's NERV Position: Q4 2016 in Review

BlackRock Investment Management reduced its Minerva Neurosciences (NERV) stake by 1.3% in Q4 2016, selling an estimated $12.5K and leaving 9,338 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

BlackRock Investment Management first reported a position in NERV in Q3 2014 and has held it in 10 quarters since. The position peaked at $1.07M in Q3 2016. 78 funds tracked by Wall St. Rank hold NERV as of Q4 2016.

BlackRock Investment Management held 9,338 shares of Minerva Neurosciences worth $878K as of Q4 2016.
BlackRock Investment Management sold 122 Minerva Neurosciences shares in Q4 2016, an estimated $12.5K.
Minerva Neurosciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2767 holding.
BlackRock Investment Management first reported a position in Minerva Neurosciences in Q3 2014 and has held it in 10 quarters since.
BlackRock Investment Management's Minerva Neurosciences position peaked at $1.07M in Q3 2016.
78 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.